Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Year: 1999
Type: article
Source: PubMed
Authors: I Wessel, L H Jensen, P B Jensen, J Falck, A Rose, M Roerth, J L Nitiss, M Sehested
Institution: Rigshospitalet
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2103697542
